Pleurodesis for malignant pleural effusions: A comparison of bleomycin or tranexamic acid alone versus a combination of both

E. Mohamed, E. Ali, H. Mahmoud (Sohag, Egypt)

Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Session: Clinical problems in mediastinal and pleural malignacies
Session type: Poster Discussion
Number: 3072
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Mohamed, E. Ali, H. Mahmoud (Sohag, Egypt). Pleurodesis for malignant pleural effusions: A comparison of bleomycin or tranexamic acid alone versus a combination of both. Eur Respir J 2013; 42: Suppl. 57, 3072

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pleurodesis success rate for malignant pleural effusions - talc slurry vs. poudrage
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Tranexamic acid versus bleomycin pleurodesis for malignant pleural effusion via tube drainage
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010


Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions
Source: Eur Respir J 2004; 24: 263-266
Year: 2004



Thoracoscopic talc Poudrage pleurodesis for malignant effusions
Source: International Congress 2015 – Interventional pulmonology for pleural diseases
Year: 2015

Iodopovidone pleurodesis in malignant pleural effusion: Is tube clamping time affected the efficacy & safety?
Source: Annual Congress 2013 –Chest wall and pleura
Year: 2013

Outcomes of bedside talc slurry pleurodesis for malignant pleural effusions: A retrospective analysis
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Talc slurry vs bleomycin in treatment of malignant pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 448s
Year: 2005

LATE-BREAKING ABSTRACT: Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE)
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


Efficacy of talc slurry pleurodesis in malignant pleural effusions
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Efficacy of cytology, cell blocks and thoracoscopic pleural biopsy in malignant pleural effusion diagnosis
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013

Pleurodesis for malignant pleural effusion: which compound?
Source: Hands-on Course 2012 - Medical Thoracoscopy
Year: 2012

Pleurodesis for malignant pleural effusion: which compound?
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013

Malignant pleural effusion: treatment of the fluid and intrapleural therapy
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020

Chemotherapy for treatment of malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 526s
Year: 2004

Intrapleural tenectaplase therapy in treatment of loculated parapneumonic pleural effusions and empyema
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015

Malignant pleural effusions
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=177
Year: 2002